ABBV vs COO
AbbVie vs Cooper Companies (The) — AI-powered side-by-side comparison
VS
COO
Cooper Companies (The)
68
Buy
| Metric | ABBV | COO |
|---|
| AI Score |
71
|
68
|
| Price |
$266.09
|
$73.45
|
| P/E Ratio |
74.52×
|
64.24×
|
| ROE |
-129.2%
|
4.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
71.5%
|
64.4%
|
| Debt / Equity |
-11.93×
|
0.30×
|
| Dividend Yield |
2.6%
|
0.0%
|
| RSI (14) |
68.7
|
54.1
|
| Beta |
0.28
|
0.823
|
| Expected Upside |
—
|
+0.1%
|
AI Committee View
Current Innellis committee reasoning for ABBV versus COO.
ABBV leads by 3 points.
ABBV scores 71/100 (Buy) versus COO at 68/100 (Buy).
ABBV Committee View
100% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
COO Committee View
80% agreement
5 analysts
The primary driver is 4 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical